Loading AI tools
Triple reuptake inhibitor investigated by the Mayo Clinic From Wikipedia, the free encyclopedia
PRC200-SS is an experimental drug of the triple reuptake inhibitor class that was investigated by the Mayo Clinic.[1][2]
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.207.294 |
Chemical and physical data | |
Formula | C20H21NO |
Molar mass | 291.394 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Preclinical toxicology studies of PRC200-SS in cynomolgus monkeys showed dose proportional kidney toxicity,[3] precluding any further drug development.
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.